The conference is organised by the Centre of Excellence in Computational Biomedicine (CompBioMed), aimed at nurturing and promoting the uptake and exploitation of high performance computing within the biomedical modelling community.

Located at the Institute of Engineering and Technology London: Savoy Place, the CompBioMed Conference 2019 will combine a venue with innovative catering and spectacular views of the River Thames with an exciting programme of relevant symposia and world-renowned plenary and invited speakers, proposed and secured by our International Organising Committee.

In addition to the conference, we have an associated event at the London Science Museum.

With the principle of 'better health for all' at its core, Horizon 2020's Societal Challenge 1 (Health, demographic change and wellbeing) focuses on:

•  personalised health and care •  infectious diseases and improving global health •  innovative and sustainable health systems •  decoding the role of the environment (including climate change) for health and wellbeing •  digital transformation •  cybersecurity in health and care

Horizon 2020 Societal Challenge 1 work programme for 2020 (2020 Health calls) will be expected to offer calls for proposals with an overall budget of about €650 million. Funding opportunities will be presented at the Open Info Day on 3 July.

Registrationss will open shortly on this website.

Related to the Open Info Day, but as a separate event, the EU-funded project Health-NCP-Net 2.0 is organizing a free of charge Partnering Event on 4 July in Brussels which is meant to assist you in finding the right project partners for the upcoming 2020 Health calls.

Registration via the NCP website will open shortly.

Biomedical imaging has revolutionised medicine, granting doctors a window into miniscule molecular and cellular processes inside the body. An EU-funded project helped to expand the view, developing innovative radiochemistry concepts and techniques that could lead to earlier diagnosis of diseases - saving lives.

EU-funded researchers have conducted the first successful trials of an innovative gene therapy to treat a rare and debilitating metabolic disorder, using a small and innocuous virus as a carrier for genetic information to correct the functioning of liver and muscle cells.

The EU-funded ENACT project has used a combination of computer simulation and experimental validation to develop more efficient and sustainable chemical processes for the energy and pharmaceutical sectors - good for the environment, health, and the EU's competitiveness.

Multi-country clinical trials have significant advantages but the practicalities of setting them up and managing them can be daunting. An EU-funded project involving 23 countries contributed to the ongoing development of an infrastructure that offers hands-on support and boosts Europe's capacity for life-saving research.

Many modern drugs are less effective than they could be because they are blocked by the body's own defences. EU-funded researchers have devised ways to bypass these barriers to get drugs to where they are needed.

Wearable sensors for at-home rehabilitation or detection of an irregular heartbeat... An EU-funded project is training students to transform healthcare in today's hyperconnected world, helping them harness the power of technology to keep patients out of hospital, cut costs and even save lives.

Using advances in electronics and software, a team of EU-funded researchers is developing new ways to control upper limb prosthetics. Their goal is to improve and facilitate the everyday lives of amputees.

Your response to a drug depends, in part, on your genetic make-up. An EU-funded project is developing a system to help doctors take into account a patient's genotype when prescribing treatment, for safer and more effective therapy.

After cardiovascular diseases, cancer is the second leading cause of death and morbidity in European countries and is one of the most significant health challenges worldwide. An EU-funded project is developing new tools for diagnosing cancer and for understanding the role of proteins in this and other major diseases.

The European Commission's Scientific Panel for Health (SPH) is a science-led expert group based on the provisions of the Horizon 2020 Specific Programme, which is tasked with helping to achieve better health and wellbeing for all.

The Panel’s main roles are to provide foresight and overall vision and strategy, as well as, to identify bottlenecks to innovation and propose solutions in the area of health and biomedical research.

Based on interactions with stakeholders during conferences and workshops, the Scientific Panel for Health set out a vision for the future of health and biomedical research in two consensus documents: ‘Better Research for Better Health’ in 2016, and a proposal ‘Building the Future of Health Research’ in 2018.

Both documents are available through the SPH website.

From further stakeholders’ consultation important topics were identified that will be the focus of the next forum to be organized with the European Commission on May 6, 2019 in Brussels: ‘Enabling health equality in Europe – the role of health research’.

The forum explores the current situation, barriers in participation and engagement with health research, and ways forward.

The SPH wishes to build an ambitious future for health research in Europe.

The forum with the European Commission is an opportunity to participate in the debate to which you are warmly invited.

For more information, please contact the SPH secretariat at SPH@p-95.com

An EU-funded project is developing software, based on artificial intelligence, that enables robots to more effectively interact with autistic children in human-led therapy sessions, helping to improve their social and communication skills.

Antimicrobial resistance (AMR) is directly linked to sanitary conditions and the population’s general state of health: the better the sanitation, the lower the problem of AMR.

European science is missing out on talent as leadership positions remain predominantly occupied by men. To challenge this gender imbalance, an EU-funded project is helping research institutes support female staff in their research career and encouraging work-life balance.

An EU and industry-funded project has developed new patient-centred tools and approaches to help people with chronic obstructive respiratory disease (CODP) get more personalised treatments - a means to boost their activity levels, health and well-being.

This year’s event is entitled "Forward as one: Healthcare Innovation and the need for policymaker engagement", and will be held in association with the Romanian Presidency of the European Union, which runs until the end of June.

More than ever before, in this crucially important year, the EAPM Conference will allow for a bridge to national representatives is order to further build on the developments that the Alliance has helped to architect in various policy areas.

It is the ideal one-stop shop, as stakeholders from every discipline and every Member State come together to forge the way ahead.

Key topics to be discussed in Brussels will include:

• Personalised Medicine and the Innovation Agenda: An Integrated Approach • Technology Developments • Hematology • Personalised Treatments and Personalised Prevention • Pharmaceutical/Diagnostics • The Regulatory Framework (Part I) • Pharmaceutical/Diagnostics • The Regulatory Framework (Part II) • Political Will and Institutional Support

Long-term vision, high-level endorsement and participation, and tailored forms of international scientific collaboration are key to overcoming widespread fragmentation and improving service quality 'and' health outcomes in Latin America. This is the overriding conclusion of an international research team backed by the European Union.

Peptidomimetics are small molecules that mimic short natural proteins - peptides - and produce the same effects as their natural counterparts. An EU-funded project is developing peptidomimetics that can alternate between biologically active and inactive forms when exposed to light. The technique could lead to new light-controlled drugs which can be turned off and on when needed to treat cancers and other diseases.

An EU-funded project has developed new approaches to tackling chronic inflammatory diseases. These will be used to create precise and individualised treatment options, potentially leading to faster diagnosis, more effective treatments and even cures.